myTomorrows

Over five months ago, brainstrust and myTomorrows joined forces with a clear objective: to simplify the discovery and access to clinical trials for people diagnosed with brain tumors and to make it easier for physicians to find relevant clinical trials for their patients. ☀️ Now, we are very excited to share that on 19th September at 12pm CEST/11am UK, our very own Tariro Mantsebo and Paris Asif will participate in the Brainstrust High Grade Knowledge Share session “Accessing Clinical Trials: How Patient Navigators can support you during your journey”. This event aims to discuss the challenges patients and caregivers face in accessing oncology trials and potential solutions to these issues. 🚀 During this insightful Q&A session, Tariro and Helen Bulbeck, Director of braintrust, will address the following questions: ✔️What does a patient navigator do, and how do they support patients and their treating physicians during their medical journey? ✔️What are some common barriers or challenges that patients face when trying to access clinical trials, and how do patient navigators help them overcome some of these obstacles? ✔️How does myTomorrows support patients and their families on a well-informed process about their clinical trial options? ➡️ You won’t want to miss this! Register for this session here https://lnkd.in/eKRvvSyU ➡️ Additionally, if you are a person with a brain tumor or a physician looking for clinical trials for your patients, visit our website to explore clinical trial treatment options https://lnkd.in/eSe_WXkH #braintrust #oncology #braincancer #clinicaltrials #patientnavigator

We’re Live at the EASD Meeting! 🚀 Our Mighties Dennis Akkaya, Rachele R. Bejjani and Paris Asif are on the ground at the #EASD in Madrid, Spain! This is one of the largest gatherings in the #diabetes field in the world, and this year’s event is particularly exciting as it marks the 60th anniversary of this meeting. Dennis, Paris, and Rachelle are actively engaging with healthcare professionals and stakeholders in the #diabetes community, having insightful discussions about the latest innovations in the field. They’re also exploring how myTomorrows can support and empower the diabetes community. If you’re attending, we’d love to connect! Drop by our booth or schedule a meeting here: https://lnkd.in/ej4WNZSv #DiabetesCare #HealthcareInnovation #ClinicalTrials #EASD2024

Breaking News!! 🚀🚀 ☀️ We are thrilled to share that our CEO, Dr. Michel van Harten, has been featured in #Forbes with an insightful article "Treating the Age of Medical Misinformation” ☀️ They say, “Knowledge is power.”💪 However, in today’s digital world, navigating the waters of online misinformation is not an easy task. In his article, Dr. van Harten discusses the dangerous implications of medical misinformation, not only for patients but also for healthcare professionals and wider BioPharma industry. 👥 One wrongly informed decision can have serious consequences. For instance, between January and March 2020, more than 5,000 people were hospitalized after a false rumor spread online that drinking concentrated alcohol-based cleaning products could “cure” COVID-19. Yet, as Dr. van Harten explains, social media and AI—when used correctly—can be part of the solution. Community groups on platforms like Facebook can offer well-informed support to individuals suffering from different conditions. Furthermore, when it comes to emerging technologies, AI is providing medical practitioners with more efficient means of detecting, diagnosing, and predicting the progression of several diseases. AI can also be used to simplify complex processes such as clinical trial identification, pre-screening and recruitment, making these processes faster and more accessible to healthcare professionals, patients and caregivers. 🌟 💡We are incredibly honored to see Dr. van Harten’s expertise recognized by Forbes, and we invite you to read the full article to explore this important topic further! Read the full article: https://lnkd.in/ed2HjTsy #Healthcare #MedicalMisinformation #AIinMedicine #myTomorrows #AI #forbes #digitalhealth

Join our growing team! 🚀 Become a part of our dynamic group of Mighties with diverse backgrounds in Medical, Pharma, Tech, and Business. This is an exciting opportunity to join our ambitious company as it grows. With benefits like flexible working, a learning and development budget, and an annual performance bonus, you’ll be based in Amsterdam with a fast-growing company of 80+ people, with 30 nationalities, helping patients to know all their treatment options.☀️ ✔️Clinical Site Manager Lead https://lnkd.in/exc9fZUz ✔️Patient Navigator (Mexico) https://lnkd.in/e3fSNRDx ✔️Supply chain Officer https://lnkd.in/epXB4Q4m Our full list: https://lnkd.in/eTD376RU   #myTomorrows #newrole #hiring #newcareer #healthcare

☀️World Duchenne Muscular Dystrophy Awareness Day☀️ Today is Duchenne Muscular Dystrophy (DMD) Awareness Day, a day to unite and raise awareness for this serious condition.💪 🌍 DMD is a genetic disorder that weakens muscles over time, with symptoms often appearing in boys between ages 2 and 3, although girls can also be affected. It is caused by mutations in the dystrophin gene, and genetic testing is typically used to diagnose the disease. Identifying the type of mutation is important as it can help predict disease progression. To learn more about how genetic testing works and its importance in managing DMD, check out this blog https://lnkd.in/eHzDnfrT 🔬Though there is no cure for DMD, treatments such as steroid drugs, physical therapy, and cardiac and respiratory care can help manage symptoms and improve quality of life. In recent years, significant progress has been made in genetic therapies aimed at correcting the genetic cause of DMD. Some of these therapies are now approved by the FDA, and more are currently under investigation in clinical trials. ➡️ At myTomorrows, our goal is to support DMD patients and caregivers on their treatment journey, as well as to assist physicians in seeking suitable clinical trials for their patients. Our dedicated Patient Navigators are available to talk with Duchenne community about what #clinicaltrials may be available to them and provide comprehensive support throughout the entire process. Book a call with us to discover your clinical treatment options. https://lnkd.in/eTQVPqEH #DMD #Duchenne #neuromuscular #musculardystrophy #clinicaltrials #raredisease

World Duchenne Awareness Day is approaching!☀️ At myTomorrows, we believe in the power of raising awareness and standing together for important causes. In anticipation of World Duchenne Awareness Day on September 7th, our team has filled our office with red balloons as a symbol of our commitment to this cause. 🎈🎈 This year marks the 11th edition of World Duchenne Awareness Day (WDAD), with the theme ‘Raise your voice for Duchenne.’ This theme emphasizes the importance of amplifying voices to advocate for the rights, inclusion and well-being of people living with Duchenne muscular dystrophy (DMD) and other dystrophinopathies.🌟 See our team standing together, holding red balloons, united in our support for everyone impacted by Duchenne Muscular Dystrophy. 🚀 #WorldDuchenneAwarenessDay #RaiseYourVoiceForDuchenne #Duchenne #DMD #RaiseAwareness #Community #TogetherWeCan

🙌 A warm welcome to our newest Mighties! We are very proud to introduce these superstars who recently joined myTomorrows. ⭐ Jonas Svensson – Senior Backend Engineer ⭐ Kristi Van Zyl – Site Manager ⭐ Madaline Kinlay – Real-World Data Associate ⭐ Alex Gleeson – Business Development Representative ⭐ Joseph Shepherd, PhD Shepherd – Medical Data Scientist ⭐ Theodor Cantero – Patient Navigator ⭐Joost den Iseger – Quality Assurance Officer ⭐ Rama Nusantara – Product Analyst ⭐ Dinesh . – Senior QA Test Engineer ⭐Pelle Wielinga – Senior Backend Engineer ⭐Zdena Lagova – Program Manager And we are still growing! 🚀 Check out our career opportunities here 👉 https://lnkd.in/etUEg8zG    #newjob #jobwithapurpose#newcareer #startuplife

We’re excited to share that myTomorrows has partnered with the CureLGMD2i Foundation!🚀 The mission of CureLGMD2i is to spread awareness, provide advocacy, and raise funds to research and support patients suffering from Limb Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9). 🔬LGMD2I/R9 is a form of Muscular Dystrophy that causes profound muscle wasting and weakness, primarily affecting the shoulders, thighs and hip muscles. While there is currently no cure for LGMD2I/R9, several investigational treatments are being explored in clinical trials. Unfortunately, accessing and navigating these trials can be challenging for those affected by the disease. 🌍 Our partnership seeks to simplify this process for patients and physicians. By using myTomorrows’ search engine, patients and physicians may more easily find relevant clinical trial options on a global scale. Additionally, myTomorrows’ patient navigators are available to provide guidance and support throughout the entire clinical trial journey, helping people with LGMD2I/R9 make the most informed decisions about their care. 🌅 Dr. Michel van Harten, CEO of myTomorrows, highlighted the value of this partnership, stating “This collaboration advances our commitment to empowering patients and healthcare professionals with the confidence and knowledge they need throughout their treatment journeys.” ➡️ Read more about this partnership here https://lnkd.in/dPNEaMEr #LGMD #LimbGirdle #MuscularDystrophy #Clinicaltrial #PatientSupport

Our very own Dennis Akkaya, Paris Asif and Rachele R. Bejjani will be soon attending the #EASD Annual Meeting in Madrid, Spain. This year’s event is particularly special as it marks the 60th anniversary of this meeting! 🎂🎈 The EASD Annual Meeting is one of the largest gatherings in the diabetes field, bringing together thousands of delegates from around the world. It’s an excellent opportunity to stay informed about the latest advancements, bridging the gap between discovery science and clinical practice. Dennis, Paris, and Rachelle are looking forward to diving into the latest innovations in the field! They are also eager to connect with physicians and industry professionals and discuss how myTomorrows can better support the #diabetes community. Interested in meeting up with our team? Book a meeting here https://lnkd.in/edCWr2Gz Or directly drop by our booth! #Diabetes #ClinicalTrials #HealthcareInnovation #clinicalpractice

Are you searching for a role at a company with an important mission? 🌍 Our founder started myTomorrows when he couldn’t find a clinical trial for his dad (who was diagnosed with cancer) in time to help him. We are a purpose-led company looking for people with endless ambition and an entrepreneurial mindset to come innovate with us. As a fast-growing startup in Amsterdam with 80+ people, we have 30+ nationalities and many great benefits, like a learning budget, flexible working, and a performance bonus just to name a few. Join us: 📐 Learn in an ever-evolving, dynamic environment. 🤝 Build up your skills in the healthcare sector. 💚 Know that you’re helping patients worldwide. ✔️Director Pharma Partneships https://lnkd.in/e62Ktu8X ✔️Clinical Site Manager Lead https://lnkd.in/e5mJx4aK ✔️Program Manager, Expanded Access Operations https://lnkd.in/e-KAHr-9 Our full list: https://lnkd.in/eXD3huwy   #WeAreMighty #newjob #hiring #newcareer